首页 | 官方网站   微博 | 高级检索  
     

自身免疫性肝炎和原发性胆汁性肝硬化患者自身免疫性甲状腺疾病流行率调查*
引用本文:徐艳,于秉楠,武剑. 自身免疫性肝炎和原发性胆汁性肝硬化患者自身免疫性甲状腺疾病流行率调查*[J]. 实用肝脏病杂志, 2022, 25(1): 42-45. DOI: 10.3969/j.issn.1672-5069.2022.01.011
作者姓名:徐艳  于秉楠  武剑
作者单位:215000 江苏省苏州市 苏州市中西医结合医院检验科(徐艳,于秉楠);苏州大学附属第一医院检验科(武剑)
基金项目:国家自然科学基金青年基金项目(编号:81503474)。
摘    要:目的 调查自身免疫性肝病(AILD)患者自身免疫性甲状腺疾病(AITD)发病率情况。 方法 2018年6月~2020年12月我院诊治的自身免疫性肝炎(AIH)41例和原发性胆汁性肝硬化(PBC)患者45例,采用间接免疫荧光法或免疫印迹法检测血清抗核抗体(ANA)、抗线粒体抗体(AMA)或AMA-M2)、抗平滑肌抗体(ASMA)、抗双链DNA抗体(抗dsDNA)和抗着丝点抗体(ACA);采用ELISA法检测血清免疫球蛋白,包括IgG、IgM和γ-球蛋白。结果 在本组41例AIH患者中,合并HT患者12例,合并GD患者6例,在45例PBC患者中,合并HT患者8例,合并GD患者7例;AIH患者血清IgG水平为17.5(14.8,19.8)g/L,显著低于AIH合并HT组【21.6(17.5,29.0)g/L,P<0.05】或AIH合并GD组【22.4(20.2,26.4)g/L,P<0.05】,血清γ-球蛋白为22.2(19.3,25.6)%,显著低于合并HT组【26.5(22.2,32.2)%,P<0.05】或合并GD组【27.1(24.3,32.0)%,P<0.05】;PBC患者年龄为(55.2±1.1)岁,显著小于合并HT组【(62.4±1.6)岁,P<0.05】或合并GD组【(62.2±1.5)岁,P<0.05】,血清IgG水平为15.4(12.2,18.0)g/L,显著低于合并HT组【20.3(16.8,24.7)g/L,P<0.05】或合并GD组【21.3(16.8,25.6)g/L,P<0.05】,血清γ-球蛋白水平为21.2(17.8,25.6)%,显著低于合并HT组【26.7(21.7,30.4)%,P<0.05】或合并GD组【25.4(22.2,29.4)%,P<0.05】。结论 AILD合并AITD的发病率较高,合并AITD患者血清IgG和γ-球蛋白水平较高,其原因还有待于进一步研究。

关 键 词:自身免疫性肝炎  原发性胆汁性肝硬化  自身免疫性甲状腺疾病  流行  
收稿时间:2021-03-24

Coincidence of autoimmune thyroid diseases in patients with autoimmune hepatitis and primary biliary cirrhosis
Xu Yan,Yu Bingnan,Wu Jian. Coincidence of autoimmune thyroid diseases in patients with autoimmune hepatitis and primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2022, 25(1): 42-45. DOI: 10.3969/j.issn.1672-5069.2022.01.011
Authors:Xu Yan  Yu Bingnan  Wu Jian
Affiliation:Clinical Laboratory, Integrated Traditional Chinese and Western Medicine Hospital, Suzhou 215000,Jiangsu Province, China
Abstract:Objective The aim of this study was to investigate the coincidence of autoimmune thyroid diseases(AITD)in patients with autoimmune hepatitis(AIH)and primary biliary cirrhosis(PBC).Methods A total of 41 patients with AIH and 45 patients with PBC were recruited in this study between June 2018 and December 2020,and serum anti-nuclear antibody(ANA),anti-mitochondrial antibody(AMA)and/or anti-mitochondrial antibody M2(AMA-M2),anti-smooth muscle antibody(ASMA),anti-double-stranded DNA antibody(anti-dsDNA)and anti-centromere antibody(ACA)were detected.Results Out of 41 patients with AIH in our series,12 patients had Hashimoto's thyroiditis(HT),and 6 had Grave’s disease(GD),and out of 45 patients with PBC,8 had HT,and 7 had GD;serum IgG level in patients with AIH was 17.5(14.8,19.8)g/L,significantly lower than[21.6(17.5,29.0)g/L,P<0.05]in patients with AIH and HT or[22.4(20.2,26.4)g/L,P<0.05]in patients with AIH and GD,serumγ-globulin level was 22.2(19.3,25.6)%,significantly lower than[26.5(22.2,32.2)%,P<0.05]in patients with AIH and HT or[27.1(24.3,32.0)%,P<0.05]in patients with AIH and GD;the age of patients with PBC was(55.2±1.1)yr old,significantly younger than[(62.4±1.6)yr old,P<0.05]in patients with PBC and HT or[(62.2±1.5)yr old,P<0.05]in patients with PBC and GD,serum IgG level was 15.4(12.2,18.0)g/L,significantly lower than[20.3(16.8,24.7)g/L,P<0.05]in patients with PBC and HT or[21.3(16.8,25.6)g/L,P<0.05]in patients with PBC and GD,serumγ-globulin level was 21.2(17.8,25.6)%,significantly lower than[26.7(21.7,30.4)%,P<0.05]in PBC patients with HT or[25.4(22.2,29.4)%,P<0.05]in patients with PBC and GD.Conclusion The coincidence of AITD in patients with AILD is common,and serum IgG andγ-globulin levels increase in patients with AIH or PBC with concomitant AITD,which needs further investigation.
Keywords:Autoimmune hepatitis  Primary biliary cirrhosis  Autoimmune thyroid diseases  Prevalence
本文献已被 维普 等数据库收录!
点击此处可从《实用肝脏病杂志》浏览原始摘要信息
点击此处可从《实用肝脏病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号